Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding Pharmacies. Iran picks new leader as escalating war deepens oil shock Heavy ...
The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...
People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
WASHINGTON, Jan 15 (Reuters) - Drugmakers Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab have been sued in Texas by a compounding pharmacy that alleges they are illegally ...
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...
GILBERT, Ariz., Jan. 14, 2026 /PRNewswire/ -- Strive Compounding Pharmacy, one of the nation's most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against ...
New Mesa campus deepens Strive’s roots in Arizona, expands production capabilities, and accelerates job creation as the company surpasses 700,000 sq. ft. of national operations. MESA, AZ / ACCESS ...
A Kennett Square pharmacy must pay a $1 million civil penalty to resolve a state investigation that found it was producing and packaging thousands of doses of injectable weight loss drugs without ...
Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...
Rep. Diana Harshbarger (R-TN) introduced legislation on Sept. 14 that would eliminate some of the bureaucratic hurdles that pharmacists face when trying to sell bespoke drugs to patients. While ...